Genesis IBRC India Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 187665,
    "name": "Genesis IBRC",
    "stock_name": "Genesis IBRC",
    "full_name": "Genesis IBRC India Ltd",
    "name_url": "stocks-analysis/genesis-ibrc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "111.20",
    "chg": -5.85,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "117.05",
    "mcapval": "152.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 514336,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 40,
    "indexname": "",
    "isin": "INE194N01016",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "144 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genesis-ibrc-187665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genesis IBRC Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genesis-ibrc-upgraded-to-sell-rating-by-marketsmojo-amid-mixed-fundamentals-3746535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRC_mojoScore_3746535.png",
        "date": "2025-12-04 11:08:06",
        "description": "Genesis IBRC, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of volatile stock returns and a complex fundamental profile."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Lower Circuit Lockdown",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3745828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3745828.png",
        "date": "2025-12-04 09:35:10",
        "description": "Genesis IBRC India Ltd has encountered severe selling pressure on 4 Dec 2025, with the stock hitting the lower circuit and registering exclusively sell orders. This distress selling signals a critical phase for the pharmaceutical and biotechnology company as it experiences consecutive losses and a sharp decline in market sentiment."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-intense-selling-pressure-amid-prolonged-downtrend-3743298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3743298.png",
        "date": "2025-12-03 09:40:10",
        "description": "Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.97% today and exhibiting a persistent downtrend over the past sixteen trading sessions. The absence of buyers and continuous sell orders have resulted in a distressing market scenario for this Pharmaceuticals & Biotechnology company."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-severe-selling-pressure-amid-lower-circuit-lock-3740939",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3740939.png",
        "date": "2025-12-02 09:35:11",
        "description": "Genesis IBRC India Ltd is currently experiencing severe selling pressure, with the stock locked in a lower circuit and an absence of buyers on the order book. This situation signals distress selling and highlights a challenging phase for the pharmaceutical and biotechnology company amid a series of consecutive losses over recent weeks."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-extreme-selling-pressure-amid-lower-circuit-lockdown-3737653",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GenesisIBRCIndi_only_sellers_3737653.png",
        "date": "2025-12-01 09:30:11",
        "description": "Genesis IBRC India has encountered significant selling pressure, with the stock registering a day marked exclusively by sell orders. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum following a prolonged period of consecutive losses."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-intense-selling-pressure-amid-prolonged-downtrend-3735425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GenesisIBRCIndi_only_sellers_3735425.png",
        "date": "2025-11-28 10:40:08",
        "description": "Genesis IBRC India is currently experiencing significant selling pressure, with the stock locked at its lower circuit and an absence of buyers in the market. This distress selling has resulted in a continuous decline over the past 13 trading sessions, signalling a challenging phase for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-intense-selling-pressure-amid-prolonged-downtrend-3733425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GenesisIBRCIndi_only_sellers_3733425.png",
        "date": "2025-11-27 10:40:11",
        "description": "Genesis IBRC India Ltd is currently experiencing significant selling pressure, with the stock locked in a lower circuit and an absence of buyers on the order book. This distress selling has resulted in a continuous decline over the past 12 trading sessions, signalling heightened investor caution in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3731294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GenesisIBRCIndi_only_sellers_3731294.png",
        "date": "2025-11-26 11:25:06",
        "description": "Genesis IBRC India Ltd is currently experiencing a pronounced selling wave, with the stock locked at its lower circuit and an absence of buyers in the queue. This extreme selling pressure has resulted in an uninterrupted decline over the past 11 trading sessions, signalling distress among investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genesis-ibrc-india-faces-extreme-selling-pressure-amid-lower-circuit-lock-3729006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GenesisIBRCIndi_only_sellers_3729006.png",
        "date": "2025-11-25 12:20:07",
        "description": "Genesis IBRC India has encountered significant selling pressure in the latest trading session, with the stock registering a decline of 2.00% while the Sensex showed a marginal gain of 0.06%. The absence of buyers and a queue dominated solely by sell orders signal distress selling, marking a notable shift in market sentiment for the pharmaceutical and biotechnology company."
      }
    ],
    "total": 170,
    "sid": "187665",
    "stock_news_url": "https://www.marketsmojo.com/news/genesis-ibrc-india-187665"
  },
  "announcements": [
    {
      "caption": "Pre-offer Advertisement and Corrigendum to the Detailed Public Statement",
      "datetime": "25-Nov-2025",
      "details": "Swaraj Shares and Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Pre-offer Advertisement and Corrigendum to the Detailed Public Statement under Regulation 18(7) in terms of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 for the attention of the Public Shareholders of Genesis Ibrc India Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Updates on Open Offer",
      "datetime": "24-Nov-2025",
      "details": "Swaraj Shares and Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (IDC) of Genesis Ibrc India Ltd (Target Company) under the provisions of Regulations 26(7) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and subsequent amendments thereto (SEBI(SAST) Regulations).",
      "source": "BSE"
    },
    {
      "caption": "Updates on Open Offer",
      "datetime": "22-Nov-2025",
      "details": "Swaraj Shares and Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Addendum cum Corrigendum to the Letter of Offer public announcement in terms of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 to the Public Shareholders of Genesis Ibrc India Ltd (Target Company).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Genesis IBRC Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-04 11:08:06

Genesis IBRC, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of volatile stock returns and a complex fundamental profile.

Genesis IBRC India Faces Intense Selling Pressure Amid Lower Circuit Lockdown

2025-12-04 09:35:10

Genesis IBRC India Ltd has encountered severe selling pressure on 4 Dec 2025, with the stock hitting the lower circuit and registering exclusively sell orders. This distress selling signals a critical phase for the pharmaceutical and biotechnology company as it experiences consecutive losses and a sharp decline in market sentiment.

Genesis IBRC India Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-03 09:40:10

Genesis IBRC India Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.97% today and exhibiting a persistent downtrend over the past sixteen trading sessions. The absence of buyers and continuous sell orders have resulted in a distressing market scenario for this Pharmaceuticals & Biotechnology company.

Genesis IBRC India Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-02 09:35:11

Genesis IBRC India Ltd is currently experiencing severe selling pressure, with the stock locked in a lower circuit and an absence of buyers on the order book. This situation signals distress selling and highlights a challenging phase for the pharmaceutical and biotechnology company amid a series of consecutive losses over recent weeks.

Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-01 09:30:11

Genesis IBRC India has encountered significant selling pressure, with the stock registering a day marked exclusively by sell orders. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum following a prolonged period of consecutive losses.

Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-28 10:40:08

Genesis IBRC India is currently experiencing significant selling pressure, with the stock locked at its lower circuit and an absence of buyers in the market. This distress selling has resulted in a continuous decline over the past 13 trading sessions, signalling a challenging phase for the pharmaceutical and biotechnology company.

Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-27 10:40:11

Genesis IBRC India Ltd is currently experiencing significant selling pressure, with the stock locked in a lower circuit and an absence of buyers on the order book. This distress selling has resulted in a continuous decline over the past 12 trading sessions, signalling heightened investor caution in the Pharmaceuticals & Biotechnology sector.

Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-26 11:25:06

Genesis IBRC India Ltd is currently experiencing a pronounced selling wave, with the stock locked at its lower circuit and an absence of buyers in the queue. This extreme selling pressure has resulted in an uninterrupted decline over the past 11 trading sessions, signalling distress among investors in the Pharmaceuticals & Biotechnology sector.

Genesis IBRC India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 12:20:07

Genesis IBRC India has encountered significant selling pressure in the latest trading session, with the stock registering a decline of 2.00% while the Sensex showed a marginal gain of 0.06%. The absence of buyers and a queue dominated solely by sell orders signal distress selling, marking a notable shift in market sentiment for the pharmaceutical and biotechnology company.

View All News